1
10FoldMed
Israeli startup developing non-invasive technology to treat obesity by reversing insulin resistance.
About
10FoldMed is an early-stage startup based in Israel with the vision to treat obesity and metabolic diseases. Their proprietary 10Fold™ technology aims to reverse insulin resistance through non-invasive destruction of visceral fat cells.
Technology stack
detected 2026-06-18Est. monthly stack spend~$2,070/mo
Email
Google Workspace
Stack
Ghost
Observability
Sentry
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does 10FoldMed do?
10FoldMed is an early-stage startup based in Israel with the vision to treat obesity and metabolic diseases. Their proprietary 10Fold™ technology aims to reverse insulin resistance through non-invasive destruction of visceral fat cells.
Where is 10FoldMed headquartered?
10FoldMed is headquartered in Tel Aviv, Israel.
When was 10FoldMed founded?
10FoldMed was founded in 2020.
What industry does 10FoldMed operate in?
10FoldMed operates in Healthcare, Obesity, MedTech, HealthTech, Biotech, Longevity.
How many employees does 10FoldMed have?
10FoldMed has approximately 7572 people on record.